Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05628974 · ClinicalTrials.gov registry record

Normal Donor Blood Draws for Platelet Studies and Biomarker Evaluation (ND-PLT)

A clinical trial of Healthy, sponsored by The Cleveland Clinic.

Recruiting
Registry status
400
Enrollment target
1
Study location

NCT05628974 is a study of Healthy that is actively recruiting participants, run by The Cleveland Clinic. The registered enrollment target is 400 participants, below the 647-participant average among 1,090 other Healthy trials with a reported enrollment target (38% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05628974, a study of Healthy, is actively recruiting participants, sponsored by The Cleveland Clinic.

RECRUITING
Registry status
400 participants
Enrollment target
1
Study location

Study Summary

This is a single-center study at the Cleveland Clinic Main Campus designed to study biomarkers in healthy individuals to identify novel mechanisms of platelet activation and how platelets drive vascular inflammation and thrombosis in diseases.

Conditions Studied

Study Locations (1)

Ohio

  • Cleveland Clinic - Cleveland

Trial Details

FieldValue
Enrollment Target 400 participants
Start Date 2020-05-01
Est. Completion 2031-06-30

Sponsor

The Cleveland Clinic

688 total trials

What the Registry Record Tells You About NCT05628974

The ClinicalTrials.gov registry entry for NCT05628974 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 400 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 647-participant average among 1,090 other Healthy trials with a reported enrollment target (38% lower). The listed sponsor is The Cleveland Clinic, which has 688 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Healthy appearing as the primary indexed condition, and to 0 interventions.

NCT05628974 reports 1 study location spanning 1 distinct geographic area - top geographies include Ohio.

Frequently Asked Questions

What is clinical trial NCT05628974 about?

NCT05628974 is a clinical study titled "Normal Donor Blood Draws for Platelet Studies and Biomarker Evaluation (ND-PLT)". This is a single-center study at the Cleveland Clinic Main Campus designed to study biomarkers in healthy individuals to identify novel mechanisms of platelet activation and how platelets drive vascular inflammation and thrombosis in diseases.

What is the current status of trial NCT05628974?

This trial is currently recruiting. The enrollment target is 400 participants. The study started on 2020-05-01. Estimated completion is 2031-06-30.

What conditions does trial NCT05628974 study?

This clinical trial studies the following conditions: Healthy.

Who is sponsoring clinical trial NCT05628974?

This trial is sponsored by The Cleveland Clinic, which has 688 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05628974 being conducted?

This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Healthy

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.